New hospital tool aims to tame blood sugar chaos

NCT ID NCT05447806

Recruiting now Disease control Sponsor: Milton S. Hershey Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a computer program that alerts doctors and nurses when hospital patients have dangerously high or low blood sugar. The tool suggests care steps to improve glucose control. Researchers will track over 15,000 adults across multiple hospitals to see if the tool reduces complications and shortens hospital stays.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Electronic medical record clinical decision support tool (GlucAlert-CDS)
What this could lead to: If successful, this tool could help hospitals better manage blood sugar levels in patients, potentially reducing complications and shortening hospital stays.
What could go wrong: This is a large but early-stage implementation study without a randomized controlled design, so results may be influenced by other factors. The tool's effectiveness may vary across different hospital settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus hyperglycemia hypoglycemia prediabetes syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES HYPERGLYCEMIA HYPERGLYCEMIA STRESS HYPOGLYCEMIA PREDIABETES

Contacts and locations

Locations

Penn State Health St. Joseph Medical Center
RECRUITING

Reading, Pennsylvania, 19605, United States
Penn State Hershey Medical Center
RECRUITING

Hershey, Pennsylvania, 17033, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.